Somatostatin News and Research

RSS
Ipsen submits Supplemental New Drug Application to FDA for Somatuline Depot 120mg injection

Ipsen submits Supplemental New Drug Application to FDA for Somatuline Depot 120mg injection

Combined chemo and radionuclide therapy stops neuroendocrine tumors

Combined chemo and radionuclide therapy stops neuroendocrine tumors

Novartis presents Phase III results of Signifor LAR therapy in patients with acromegaly

Novartis presents Phase III results of Signifor LAR therapy in patients with acromegaly

Professor receives 2014 Rolf Luft Award for research on diabetes and endocrinology

Professor receives 2014 Rolf Luft Award for research on diabetes and endocrinology

AAA gets orphan drug designation status for radiopharmaceutical, Gallium-68 DOTATATE

AAA gets orphan drug designation status for radiopharmaceutical, Gallium-68 DOTATATE

Drugs often fail to bring acromegaly under control in routine clinical practice

Drugs often fail to bring acromegaly under control in routine clinical practice

Pancreatic protein essential for maintaining functional state of beta cells

Pancreatic protein essential for maintaining functional state of beta cells

Neuroscientists identify key circuit elements that contribute to everyday decision in ACC

Neuroscientists identify key circuit elements that contribute to everyday decision in ACC

Chiasma, Roche enter agreement to develop and commercialize Octreolin

Chiasma, Roche enter agreement to develop and commercialize Octreolin

Study examines how fear responses are learned, controlled and memorized

Study examines how fear responses are learned, controlled and memorized

FDA approves Novartis Signifor injection for treatment of Cushing's disease

FDA approves Novartis Signifor injection for treatment of Cushing's disease

Radiopharmaceutical Tektrotyd continues to receive interest and recognition

Radiopharmaceutical Tektrotyd continues to receive interest and recognition

FDA EMDAC votes unanimously in support of Signifor use for treatment of Cushing's disease

FDA EMDAC votes unanimously in support of Signifor use for treatment of Cushing's disease

Two major classes of brain cells repress neural activity in specific mathematical ways

Two major classes of brain cells repress neural activity in specific mathematical ways

Novartis’ pasireotide offers symptom relief for patients with advanced neuroendocrine tumors

Novartis’ pasireotide offers symptom relief for patients with advanced neuroendocrine tumors

Novel multireceptor-targeted somatostatin analogue found effective against neuroendocrine tumors

Novel multireceptor-targeted somatostatin analogue found effective against neuroendocrine tumors

Researchers use metal complexes to modify peptide hormones

Researchers use metal complexes to modify peptide hormones

New somatostatin vaccines promote weight loss

New somatostatin vaccines promote weight loss

Combination treatment improves progression-free survival in pancreatic neuroendocrine tumors

Combination treatment improves progression-free survival in pancreatic neuroendocrine tumors

New guidelines for the treatment of acromegaly, a serious growth hormone disorder

New guidelines for the treatment of acromegaly, a serious growth hormone disorder